Healthcare -
Biotechnology - NASDAQ - US
$ 15.85
5.46 %
$ 482 M
Market Cap
-2.62
P/E
ANAB - TOTAL CURRENT LIABILITIES
Total Current Liabilities ANAB - AnaptysBio, Inc.
37.4 M
LAST VALUE
52.50%
2 YEAR CAGR
11.39%
5 YEAR CAGR
28.04%
10 YEAR CAGR